Issue Information
- 期刊名称Risk, Hazards & Crisis in Public Policy
- 卷第3卷
- 期第3期
- 印刷ISSN1944-4079
- 文件大小31.23KB
- 发表时间2012-09
- DOI10.1002/rhc3.7
- 页码1-103
Efficacy and Safety of Irbesartan/HCTZ Combination Therapy As Initial Treatment for Rapid Control of Severe HypertensionJoel M. Neutel; Stanley S. Franklin; Suzanne Oparil; Amitabha Bhaumik; Agata Ptaszynska; Pablo Lapuerta · 2006
PRESERVE- : Two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metforminGerich, J.; Raskin, P.; Jean-Louis, L.; Purkayastha, D.; Baron, M. A. · Diabetes Care · 2005
Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertensionSalam, Abdul; Kanukula, Raju; Atkins, Emily; Wang, Xia; Islam, Shariful; Kishore, Sandeep P.; Jaffe, Marc G.; Patel, Anushka; Rodgers, Anthony · Journal of Hypertension · 2019
Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week studyWilliams-Herman, Debora; Johnson, Jeremy; Teng, Rujun; Luo, Edmund; Davies, Michael J.; Kaufman, Keith D.; Goldstein, Barry J.; Amatruda, John M. · 2009
Efficacy and safety of initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes: a 54-week studyK. H. Yoon; H. Steinberg; R. Teng; G. T. Golm; M. Lee; E. A. O'Neill; K. D. Kaufman; B. J. Goldstein · 2012
Safety and Efficacy of Palbociclib and Radiation Therapy in Patients With Metastatic Breast Cancer: Initial Results of a Novel CombinationChowdhary, Mudit; Sen, Neilayan; Chowdhary, Akansha; Usha, Lydia; Cobleigh, Melody A.; Wang, Dian; Patel, Kirtesh R.; Barry, Parul N.; Rao, Ruta D. · Advances in Radiation Oncology · 2019
Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapyEric Katz; L.Scott Larsen; Charles M. Fogarty; Kamal Hamed; James Song; Shurjeel Choudhri · 2004
Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetesD. Williams-Herman; J. Johnson; R. Teng; G. Golm; K. D. Kaufman; B. J. Goldstein; J. M. Amatruda · 2010
News and ViewsIdris, Iskandar · Diabetes, Obesity and Metabolism · 2013
News and ViewsIdris, Iskandar · Diabetes, Obesity and Metabolism · 2013
Issue InformationDiabetes, Obesity and Metabolism · 2013
Issue InformationDiabetes, Obesity and Metabolism · 2013
Issue InformationDiabetes, Obesity and Metabolism · 2013
Leptin therapy in type 2 diabetesCummings, B. P. · Diabetes, Obesity and Metabolism · 2013
Macrophages control innate inflammationAkira, S.; Misawa, T.; Satoh, T.; Saitoh, T. · Diabetes, Obesity and Metabolism · 2013
Diabetes, Obesity and MetabolismDiabetes, Obesity and Metabolism · 2014